IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 66 filers reported holding IMMUNIC INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $488,203 | -46.4% | 332,111 | -8.5% | 0.00% | – |
Q2 2023 | $910,977 | +86.0% | 362,939 | +10.4% | 0.00% | – |
Q1 2023 | $489,872 | -27.5% | 328,773 | -31.9% | 0.00% | – |
Q4 2022 | $675,510 | +209.9% | 482,507 | +601.7% | 0.00% | – |
Q3 2022 | $218,000 | -30.6% | 68,767 | -23.9% | 0.00% | – |
Q2 2022 | $314,000 | -81.6% | 90,384 | -40.0% | 0.00% | – |
Q1 2022 | $1,703,000 | +236.6% | 150,720 | +185.5% | 0.00% | – |
Q4 2021 | $506,000 | +462.2% | 52,800 | +417.6% | 0.00% | – |
Q3 2021 | $90,000 | -90.8% | 10,200 | -87.3% | 0.00% | – |
Q2 2021 | $981,000 | -55.2% | 80,031 | -41.7% | 0.00% | – |
Q1 2021 | $2,189,000 | -50.8% | 137,361 | -52.8% | 0.00% | – |
Q4 2020 | $4,446,000 | +105.5% | 290,860 | +149.5% | 0.00% | – |
Q3 2020 | $2,164,000 | +220.1% | 116,559 | +108.9% | 0.00% | – |
Q2 2020 | $676,000 | +103.0% | 55,800 | 0.0% | 0.00% | – |
Q1 2020 | $333,000 | -68.8% | 55,800 | -49.3% | 0.00% | – |
Q4 2019 | $1,067,000 | -3.7% | 110,000 | 0.0% | 0.00% | – |
Q3 2019 | $1,108,000 | -12.8% | 110,000 | -0.6% | 0.00% | – |
Q2 2019 | $1,270,000 | – | 110,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
Logos Global Management LP | 421,184 | $619,140 | 0.08% |
Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |